1. Neopterin serum level does not reflect the disease activity in rheumatoid arthritis: A systematic review and meta-analysis
- Author
-
Davood Bashash, Parisa Zafari, Alireza Hejrati, Mozhgan Esmaili, Reza Alizadeh-Navaei, Mahdi Taghadosi, and Shahnaz Hosseinzadeh
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Clinical Biochemistry ,Inflammation ,Biochemistry ,Neopterin ,Severity of Illness Index ,Disease activity ,Arthritis, Rheumatoid ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Genetics ,medicine ,Animals ,Humans ,Molecular Biology ,Autoimmune disease ,business.industry ,Cell Biology ,medicine.disease ,Confidence interval ,030104 developmental biology ,Systematic review ,chemistry ,030220 oncology & carcinogenesis ,Meta-analysis ,Rheumatoid arthritis ,medicine.symptom ,business ,Biomarkers - Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease caused by established chronic inflammation. Neopterin levels have extensively been considered as a marker of immune activation during inflammation. In this study, we performed a systematic evaluation and meta-analysis to elucidate the overall relationship between neopterin concentration and RA disease activity. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, a systematic review was conducted using PubMed, Google Scholar, Web of Science, and Scopus from 2000 to August 2020. The Newcastle-Ottawa scale was used to assess the quality of eligible studies. The effect size (ES) and corresponding 95% confidence intervals (CIs) were calculated to evaluate this association. A total of 15 studies out of 98 met our inclusion criteria. The pooled analysis found that patients with RA had high level of neopterin; however, no statistically significant association was found between neopterin levels with high, intermediate, and low diseases activity score (DAS)-28 (ES =11.18, 95% CI: 6.02 to 16.34, and I2 = 91.8%; and ES = 8.57, 95% CI: 6.41 to 10.37, and I2 = 99.5%; and ES =12.45, 95% CI: -1.68 to 26.58, and I2 = 99.0%, respectively). Our results indicated that the neopterin concentration does not seem to have any substantial impact on the RA disease activity.
- Published
- 2020